Lung cancer is the most common cancer in the world. It is the most malignant type, prone to metastasis, spreading from the lungs to the lymph nodes and other organs in the body. Lung cancer is divided into two types: small cell lung cancer and non-small cell lung cancer. They are diagnosed based on the appearance of the cells under a microscope. Non-small cell lung cancer is more common (accounting for about 85%) and includes the subtypes: squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Small cell lung cancer is less common (about 15%) and is considered the most dangerous form of lung cancer because it grows about twice as fast as other types and quickly metastasizes to distant sites (such as the brain).


People who smoke have a higher risk of lung cancer than non-smokers. This risk increases with the duration and amount of tobacco smoked. If you quit smoking, even after many years, you can still significantly reduce your risk of lung cancer.
The signs and symptoms of lung cancer usually appear only when the disease has reached an advanced stage. It is one of the most common cancers in men and a leading cause of cancer-related death in men.
Lung cancer usually does not cause obvious symptoms in its early stages, which makes early detection difficult without screening tests.
Non-small cell lung cancer has 4 main stages, as follows:
Stage 1: Cancer cells are found in the lung but have not spread to the lymph nodes or other organs.
Stage 2: Cancer cells are found in the lung and have spread to areas around the lung, such as the chest wall, the pleura, nearby lymph nodes, or the membrane surrounding the heart.
Stage 3: Cancer cells begin to spread further to other areas, specifically within the chest, between the heart and the lungs. The cancer may spread to the lower neck.
Stage 4: The cancer has spread to the other lung, the areas surrounding the lungs, or distant organs. At this stage, the cancer cells can no longer be removed by surgery.
Chronic obstructive pulmonary disease, also known as COPD, is a chronic lung disease that obstructs airflow out of the lungs. Symptoms include shortness of breath, cough, phlegm, and wheezing. People with the following conditions are at risk of COPD: Emphysema – lung damage caused by smoking or by long-term inhalation of irritant gases and other particles, in which the alveoli (the small air sacs in the lungs) are destroyed. Chronic bronchitis – a persistent cough accompanied by phlegm. COPD symptoms often do not appear until the lungs are significantly damaged, and they usually worsen over time, especially if smoking continues. In Vietnam, COPD has an even higher mortality rate than deaths from traffic accidents. People with COPD have a higher risk of cardiovascular disease, lung cancer, and many other conditions. The disease can be prevented if detected early. Most patients can control their symptoms while reducing the risk of complications.
Regular health check-ups help detect lung conditions, including after a Covid-19 infection.
More accurate with AI technology & modern CT scanning
At GC&Phenikaa, we apply new-generation low-dose computed tomography integrated with artificial intelligence (AI) to analyze lung images with outstanding accuracy. The AI system calculates in detail the areas of reduced alveolar density and evaluates them using the Goddard score – an international standard in COPD diagnosis. As a result, patients benefit from: